OnDemand WTP Pricing Research

JAMA study: The cost of brand-name prescription drugs doubles every 7 to 8 years | MarketWatch

The costs of these top-selling drugs saw a median increase of 76% over the six-year period, according to new research published in JAMA Network Open, with the prices of most increasing either once or twice annually. JAMA is the Journal of the American Medical Association.

The findings suggest that the cost of popular brand-name drugs double every seven to eight years. And the situation doesn’t seem likely to improve, the study by Scripps Research Translational Institute researchers found. “Greater price transparency is warranted,” they said.

Some 48 out of 49 most common brand-name prescription drugs in the U.S. got more expensive between early 2012 and late 2017. All this data suggest that these products — and even emerging ones — are likely to continue escalating in price, they added.

The researchers studied drugs that exceeded $500 million in U.S. sales or $1 billion globally, had more than 100,000 pharmacy claims during those six years, and had available net price data. (Pharmacy claims are sent to the payer for a payment decision.)

Read complete article here:

JAMA study: The cost of brand-name prescription drugs doubles every 7 to 8 years – MarketWatch.

Post a Comment

WP-SpamFree by Pole Position Marketing